Development and validation of a volumetric absorptive microsampling- liquid chromatography mass spectrometry method for the analysis of cefepime in human whole blood: Application to pediatric pharmacokinetic study.
Development and validation of a volumetric absorptive microsampling- liquid chromatography mass spectrometry method for the analysis of cefepime in human whole blood: Application to pediatric pharmacokinetic study.
复制标题
用于分析人全血中头孢吡肟的体积吸收微量采样-液相色谱质谱法的开发和验证:在儿科药代动力学研究中的应用。
DOI:
10.1016/j.jpba.2019.113002
复制
发表时间:
2020
影响因子:
3.4
通讯作者:
Zuppa,AthenaF
中科院分区:
文献类型:
--
作者:
Moorthy,GaneshS;Vedar,Christina;Zane,NicoleR;Downes,KevinJ;Prodell,JaniceL;DiLiberto,MaryAnn;Zuppa,AthenaF
Cefepime is a fourth-generation cephalosporin antibiotic with an extended spectrum of activity against many Gram-positive and Gram-negative bacteria. There is a growing need to develop sensitive, small volume assays, along with less invasive sample collection to facilitate pediatric pharmacokinetic clinical trials and therapeutic drug monitoring. The volumetric absorptive microsampling (VAMS™) approach provides an accurate and precise collection of a fixed volume of blood (10 μL), reducing or eliminating the volumetric blood hematocrit assay-bias associated with the dried blood spotting technique. We developed a high-performance liquid chromatographic method with tandem mass spectrometry detection for quantification of cefepime. Sample extraction from VAMS™ devices, followed by reversed-phase chromatographic separation and selective detection using tandem mass spectrometry with a 4 min runtime per sample was employed. Standard curves were linear between 0.1–100 μg/mL for cefepime. Intra- and inter-day accuracies were within 95.4–113% and precision (CV) was < 15 % based on a 3-day validation study. Recoveries ranged from 40.8 to 62.1% and the matrix effect was within 89.5–96.7% for cefepime. Cefepime was stable in human whole blood under assay conditions (3 h at room temperature, 24 h in autosampler post-extraction). Cefepime was also stable for at least 1 week (7 days) at 4 °C, 1 month (39 days) at −20 °C and 3 months (91 days) at −78 °C as dried microsamples. This assay provides an efficient quantitation of cefepime and was successfully implemented for the analysis of whole blood microsamples in a pediatric clinical trial.
登录
查看更多内容
影响因子:
6.2
作者:
De Kesel, Pieter M. M.;Lambert, Willy E.;Stove, Christophe P.
通讯作者:
Stove, Christophe P.
影响因子:
--
作者:
G. Moorthy;K. Downes;Nicole R. Zane;A. Zuppa
通讯作者:
A. Zuppa
DOI:
10.1016/j.jpba.2018.04.001
发表时间:
2018-07-15
影响因子:
3.4
作者:
Xie, Iris;Xu, Yang;Bateman, Kevin P.
通讯作者:
Bateman, Kevin P.
影响因子:
4.9
作者:
Bugnon, D;Giannoni, E;Moreillon, P
通讯作者:
Moreillon, P
影响因子:
1.8
作者:
Spooner, Neil;Denniff, Philip;Rudge, James B.
通讯作者:
Rudge, James B.